Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0092 | 0.9 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0033 | 1 |